Claudio Corallo

1.0k total citations
32 papers, 770 citations indexed

About

Claudio Corallo is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Dermatology. According to data from OpenAlex, Claudio Corallo has authored 32 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 11 papers in Molecular Biology and 5 papers in Dermatology. Recurrent topics in Claudio Corallo's work include Systemic Sclerosis and Related Diseases (17 papers), Connective Tissue Growth Factor Research (5 papers) and Dermatologic Treatments and Research (4 papers). Claudio Corallo is often cited by papers focused on Systemic Sclerosis and Related Diseases (17 papers), Connective Tissue Growth Factor Research (5 papers) and Dermatologic Treatments and Research (4 papers). Claudio Corallo collaborates with scholars based in Italy, United States and Belgium. Claudio Corallo's co-authors include N. Giordano, Niccolò Nuti, Marco Ferrari, Behzad Gerami‐Naini, Ranuccio Nuti, Antonella Fioravanti, Giovanni Vozzi, Maurizio Cutolo, Sara Cheleschi and Sara Tenti and has published in prestigious journals such as Scientific Reports, Annals of the Rheumatic Diseases and Journal of Applied Polymer Science.

In The Last Decade

Claudio Corallo

31 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudio Corallo Italy 15 228 173 147 136 93 32 770
Sebastian Willenborg Germany 17 399 1.8× 115 0.7× 178 1.2× 94 0.7× 171 1.8× 29 1.5k
Yannic Danger France 8 266 1.2× 60 0.3× 104 0.7× 131 1.0× 107 1.2× 19 971
Takehiko Yamazaki Japan 12 307 1.3× 64 0.4× 211 1.4× 100 0.7× 98 1.1× 20 813
Matthew P. Murphy United States 12 163 0.7× 65 0.4× 128 0.9× 94 0.7× 146 1.6× 28 643
Cinzia Manuelli Italy 18 242 1.1× 106 0.6× 345 2.3× 43 0.3× 123 1.3× 30 1.2k
Niwa Ali United Kingdom 13 318 1.4× 58 0.3× 93 0.6× 57 0.4× 116 1.2× 21 1.9k
Xin Yan China 16 273 1.2× 51 0.3× 95 0.6× 61 0.4× 100 1.1× 56 799
Elisa Montanari Switzerland 16 149 0.7× 344 2.0× 93 0.6× 78 0.6× 254 2.7× 25 907

Countries citing papers authored by Claudio Corallo

Since Specialization
Citations

This map shows the geographic impact of Claudio Corallo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Corallo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Corallo more than expected).

Fields of papers citing papers by Claudio Corallo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Corallo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Corallo. The network helps show where Claudio Corallo may publish in the future.

Co-authorship network of co-authors of Claudio Corallo

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Corallo. A scholar is included among the top collaborators of Claudio Corallo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Corallo. Claudio Corallo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Westhovens, René, Rieke Alten, Lorenzo Dagna, et al.. (2023). POS0829 SAFETY AND EFFICACY OF FILGOTINIB: AN UPDATE FROM THE DARWIN 3 PHASE 2 LONG-TERM EXTENSION WITH A MAXIMUM OF 8.2 YEARS OF EXPOSURE. Annals of the Rheumatic Diseases. 82. 712–713. 1 indexed citations
2.
Corallo, Claudio, Angelique van den Heuvel, Thomas Olivier, et al.. (2022). High-throughput 3D microvessel-on-a-chip model to study defective angiogenesis in systemic sclerosis. Scientific Reports. 12(1). 16930–16930. 22 indexed citations
3.
Cutolo, Maurizio, Stefano Soldano, P. Montagna, et al.. (2020). Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts:in vitrostudy. Lara D. Veeken. 59(12). 3927–3938. 9 indexed citations
4.
Corallo, Claudio, et al.. (2019). Sarcopenia in systemic sclerosis: the impact of nutritional, clinical, and laboratory features. Rheumatology International. 39(10). 1767–1775. 32 indexed citations
5.
Cheleschi, Sara, Sara Tenti, Nicola Mondanelli, et al.. (2019). MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes. Cells. 8(8). 874–874. 66 indexed citations
6.
Corallo, Claudio, Sara Cheleschi, Maurizio Cutolo, et al.. (2019). Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?. Arthritis Research & Therapy. 21(1). 152–152. 16 indexed citations
7.
8.
Ceccarelli, Elena, et al.. (2019). Hyperglycemia and Diabetes Induced by Glucocorticoids in Nondiabetic and Diabetic Patients: Revision of Literature and Personal Considerations. Current Pharmaceutical Biotechnology. 19(15). 1210–1220. 39 indexed citations
9.
Cutolo, Maurizio, Barbara Ruaro, P. Montagna, et al.. (2018). Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts. Arthritis Research & Therapy. 20(1). 77–77. 23 indexed citations
10.
11.
Cheleschi, Sara, Antonella Fioravanti, Claudio Corallo, et al.. (2018). Methylsulfonylmethane and mobilee prevent negative effect of IL-1β in human chondrocyte cultures via NF-κB signaling pathway. International Immunopharmacology. 65. 129–139. 24 indexed citations
12.
Soldano, Stefano, P. Montagna, R. Brizzolara, et al.. (2017). AB0185 Endothelin-1 stimulates the profibrotic alternative activated phenotype in cultured human macrophages isolated from systemic sclerosis patients. Annals of the Rheumatic Diseases. 76. 1111–1111. 1 indexed citations
13.
Corallo, Claudio, Maurizio Cutolo, Bashar Kahaleh, et al.. (2016). Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. Arthritis Research & Therapy. 18(1). 228–228. 30 indexed citations
14.
Corallo, Claudio, Annalisa Santucci, Giulia Bernardini, et al.. (2016). Proteomic Investigation of Dermal Fibroblasts Isolated from Affected and Unaffected Skin Samples from Patients with Limited Cutaneous Systemic Sclerosis: 2 Distinct Entities?. The Journal of Rheumatology. 44(1). 40–48. 13 indexed citations
15.
Nuti, Niccolò, et al.. (2016). Multipotent Differentiation of Human Dental Pulp Stem Cells: a Literature Review. Stem Cell Reviews and Reports. 12(5). 511–523. 222 indexed citations
16.
Corallo, Claudio, Emilio Battisti, Roberto Leoncini, et al.. (2013). Proteomics of human primary osteoarthritic chondrocytes exposed to extremely low-frequency electromagnetic fields (ELF EMFs) and to therapeutic application of musically modulated electromagnetic fields (TAMMEF). Electromagnetic Biology and Medicine. 33(1). 3–10. 10 indexed citations
17.
Giordano, N., Nila Volpi, Claudio Corallo, et al.. (2012). Expression of RXFP1 in skin of scleroderma patients and control subjects. Scandinavian Journal of Rheumatology. 41(5). 391–395. 15 indexed citations
18.
19.
Vozzi, Giovanni, Claudio Corallo, & Chiara Daraio. (2012). Pressure‐activated microsyringe composite scaffold of poly(L‐lactic acid) and carbon nanotubes for bone tissue engineering. Journal of Applied Polymer Science. 129(2). 528–536. 26 indexed citations
20.
Giordano, N., et al.. (2012). Erythema nodosum associated with Staphylococcus xylosus septicemia. Journal of Microbiology Immunology and Infection. 49(1). 134–137. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian Willenborg Breakdown of academic impact, for papers by Yannic Danger Breakdown of academic impact, for papers by Takehiko Yamazaki Breakdown of academic impact, for papers by Matthew P. Murphy Breakdown of academic impact, for papers by Cinzia Manuelli Breakdown of academic impact, for papers by Niwa Ali Breakdown of academic impact, for papers by Xin Yan Breakdown of academic impact, for papers by Elisa Montanari
Rankless by CCL
2026